Guangdong Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- -
- Market Cap
- -
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
Phase 2
Recruiting
- Conditions
- Triple Negative Breast Cancer
- Interventions
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT04877821
- Locations
- 🇨🇳
NeoSACT, Guangzhou, Guangdong, China
The Effect of HIIT, MICT in Patients With Myocardial Infarction
Not Applicable
- Conditions
- Cardiopulmonary DiseaseTraining Group, SensitivityMyocardial Infarction
- Interventions
- Behavioral: High Intensity Interval Training(HIIT）Behavioral: Moderate Intensity Continuous Training(MICT）
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2021-12-09
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT04863677
- Locations
- 🇨🇳
Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
- Interventions
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 57
- Registration Number
- NCT04858516
Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)
Phase 3
Recruiting
- Conditions
- Neoadjuvant Therapies for HER2+ Breast Cancer
- Interventions
- Drug: investigator-selected taxane/trastuzumab/pertuzumab (THP)Drug: investigator-selected taxane/carboplatin/trastuzumab/pertuzumab (TCHP)
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 774
- Registration Number
- NCT04858529
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
Observational Study for Patients With Hypertrophic Cardiomyopathy
Recruiting
- Conditions
- HCM - Hypertrophic Cardiomyopathy
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04851652
- Locations
- 🇨🇳
Guangdong cardiovascular institute, Guangzhou, Guangdong, China
Observational Study for Patients With Dilated Cardiomyopathy
Recruiting
- Conditions
- DCM - Dilated Cardiomyopathy
- Interventions
- Other: No intervention nor exposure
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04837612
- Locations
- 🇨🇳
Guangdong cardiovascular institute, Guangzhou, Guangdong, China
A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 155
- Registration Number
- NCT04822103
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
🇨🇳Shantou Central Hospital, Shantou, Guangdong, China
Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy
Not Applicable
- Conditions
- Nasopharyngeal CarcinomaMalnutrition
- Interventions
- Dietary Supplement: oral nutritional supplements
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 272
- Registration Number
- NCT04810936
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)
Not Applicable
- Conditions
- Intramural Hematoma
- Interventions
- Procedure: Thoracic endovascular aortic repair plus optimal medical therapyDrug: Optimal medical therapy
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 154
- Registration Number
- NCT04808661
- Locations
- 🇨🇳
#106 Dongchuan Second Road, Yuexiu District, Guangzhou, Guangdong, China
Continuous Heparin Infusion to Prevent Catheter-related Thrombosis
Not Applicable
Completed
- Conditions
- Cardiac SurgeryCentral Venous Catheter ThrombosisHeparin
- Interventions
- Drug: Normal saline
- First Posted Date
- 2021-02-23
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT04767113
- Locations
- 🇨🇳
Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath